ABI-5366

· Assembly Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABI-5366, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes [Phase 1]

See pricing